Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Electroporation × Genitourinary × Clear all

Phase

Status

Unknown 6 Completed 4 Recruiting 3 Withdrawn 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 1

Interventions

pembrolizumab 68 Nivolumab 60 Magnetic Resonance Spectroscopy 56 enzalutamide 37 Radiosurgery 37 Gemcitabine 37 Abiraterone Acetate 36 Radiotherapy 34 Prednisone 34 Specimen Handling 33 Ipilimumab 32 apalutamide 30 Docetaxel 30 Cisplatin 30 Androgen Antagonists 28 Leuprolide 27 Carboplatin 27 atezolizumab 26 durvalumab 22 cabozantinib 22 acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 19 Goserelin 19 darolutamide 18 olaparib 17 Radiation 17 Gonadotropin-Releasing Hormone 17 Biopsy 17 gallium 68 PSMA-11 16 Pluvicto 16 bicalutamide 15

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05345444 2026-03-25

RTIRE

Weill Medical College of Cornell University

Phase NA Active not recruiting

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡